Literature DB >> 4719570

Cell-mediated immunity to human tumors. Abrogation by serum factors and nonspecific effects of oral BCG therapy.

R E Falk, P Mann, B Langer.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1973        PMID： 4719570     DOI： 10.1001/archsurg.1973.01350200123026

Source DB:  PubMed          Journal:  Arch Surg        ISSN： 0004-0010


× No keyword cloud information.
  6 in total

Review 1.  [The immunology of malignant melanoma (author's transl)].

Authors:  G Schieferstein
Journal:  Klin Wochenschr       Date:  1978-03-15

2.  [Influence of autologous serum on leucocyte-migration-inhibition-test in melanomalignoma (author's transl)].

Authors:  J Fritz; K Grond
Journal:  Arch Dermatol Res       Date:  1977-04-27       Impact factor: 3.017

Review 3.  Trained Innate Immunity and Its Implications for Mucosal Immunity and Inflammation.

Authors:  George Hajishengallis; Xiaofei Li; Ioannis Mitroulis; Triantafyllos Chavakis
Journal:  Adv Exp Med Biol       Date:  2019       Impact factor: 2.622

4.  [Cellular immunity in melanomalignome (author's transl)].

Authors:  J Fritz; K Grond; G P Tilz
Journal:  Arch Dermatol Res       Date:  1976-04-21       Impact factor: 3.017

5.  Human intracranial tumors: effect of autologous serum addition on leucocyte migration inhibition.

Authors:  D K Böker
Journal:  Acta Neurochir (Wien)       Date:  1982       Impact factor: 2.216

6.  Influence of orally administered B.C.G. on growth of transplanted rat tumours.

Authors:  R W Baldwin; D G Hopper; M V Pimm
Journal:  Br J Cancer       Date:  1975-01       Impact factor: 7.640
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.